Covid-19 Statement The health and safety of our patients, our employees and their families are Ferring’s number one priority. As the situation regarding COVID-19 continues to develop, Ferring is committed to following appropriate global, regional and local medical authority guidance to prevent infection spread and to keep patients, our employees and their families safe. This also applies to how we maintain contact with Healthcare Professionals in our therapy areas, where we will follow the guidance of the relevant Healthcare Professionals and their institutions regarding in-person visits, and respect good practice infection control measures during such visits. Ferring sales representatives, medical staff and brand managers will also remain available to contact remotely via phone or email where that is the preferred route of communication. In addition to policies to protect our employees and prevent infection spread, we have also put in place plans to avoid disruption in manufacturing and ensure continuity of supply of our treatments to doctors and patients around the world If you have questions for Ferring, please email customer.services@ferring.com or call 0800 111 4125 to get in touch with our teams. For adverse event reporting please contact medical.uk@ferring.com. Alternatively, please call 0800 111 4126. Sitemap UK-nonP-2000016 Date of preparation: October 2021 © 2021 Ferring Pharmaceuticals Limited. All rights reserved UK Office Ferring Pharmaceuticals Ltd Drayton Hall, Church Road West Drayton UB7 7PS Tel: +44(0)844 931 0050